NCT05409131: A trial that was reported late by Insulet Corporation
This trial has reported, although it was 59 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05409131 |
|---|---|
| Title | Efficacy and Safety of the Omnipod 5 System Compared to Pump Therapy in the Treatment of Type 1 Diabetes: a Randomized, Parallel-group Clinical Trial |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 7, 2022 |
| Completion date | Sept. 14, 2023 |
| Required reporting date | Sept. 13, 2024, midnight |
| Actual reporting date | Nov. 12, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 59 |